Shire Billed Medicaid For Off-Label ADHD Drug Use, La. Says

Law360, New York (August 20, 2013, 6:07 PM EDT) -- Irish drugmaker Shire PLC and its U.S. unit were targeted by the Louisiana attorney general in a suit removed to federal court Monday that claims they promoted certain attention deficit hyperactivity disorder drugs for off-label uses and obtained federal Medicare reimbursements for such improper use.

The drugmaker argued the suit belongs in federal court because it involves federal issues including alleged violations of the Federal Food, Drug, and Cosmetic Act, as well as Shire’s alleged submission of false claims to Medicaid for ADHD prescriptions that were...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

State of Louisiana v. Shire,PLC et al


Case Number

3:13-cv-00543

Court

Louisiana Middle

Nature of Suit

Other Statutory Actions

Judge

James J. Brady

Date Filed

August 19, 2013

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.